Exploring The Role Of Selenium And Its Nanoformulation In The Progression Of Neurodegenerative Diseases: A Review
DOI:
https://doi.org/10.63278/mme.vi.1832Abstract
Selenium has been used traditionally for its various roles in traditional dosage forms, specifically for enhancing memory and overall human health. As per a recent research study, selenium is found to be safe. The positive role of selenium and its protein (SELENOP) promises to control and manage neurodegenerative diseases by directly and indirectly interacting with the pathophysiology of neurodegenerative diseases like Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). Selenium, combined with established drugs for neurodegenerative diseases, is explored in its nanoformulation, elevating its therapeutic action. Selenium can be a good candidate in exploring prevention and managing less explored diseases like Huntington's disease (HD) and other neurodegenerative diseases. Selenium is used as a neuroprotective agent by redox regulation and antioxidant defense mechanisms, which protect neurons from oxidative damage.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 Dhara Pandey, Dr. Kunal M. Gokhale

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their published articles online (e.g., in institutional repositories or on their website, social networks like ResearchGate or Academia), as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Except where otherwise noted, the content on this site is licensed under a Creative Commons Attribution 4.0 International License.



According to the